¼¼°èÀÇ ³ú°æ»ö Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Cerebral Infarction Treatment Global Market Report 2025
»óǰÄÚµå : 1764280
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,993,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,765,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

³ú°æ»ö Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 7.0%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇϸç 155¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ³ëÀÎ Àα¸ÀÇ È®´ë, ³úÁ¹Áß À¯º´·ü Áõ°¡, ³úÇ÷°ü Áúȯ ¹× ½ÉÇ÷°üÁúȯÀÇ Áõ°¡, ³ú°æ»ö ¹ß»ý·üÀÇ Áõ°¡¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¿ø°ÝÀÇ·áÀÇ ÅëÇÕ, ¿þ¾î·¯ºí °Ç°­ ¸ð´ÏÅ͸µ ±â±âÀÇ »ç¿ë, ½Å°æ ¿µ»ó ±â¼úÀÇ ¹ßÀü, ·Îº¿ º¸Á¶ ¼ö¼úÀÇ Ã¤ÅÃ, ³ª³ë±â¼úÀ» ÅëÇÑ ¾à¹°Àü´Þ ½Ã½ºÅÛ, °¡»ó ÀçȰ Ç÷§ÆûÀÇ °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

³úÁ¹Áß À¯º´·üÀÇ Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È ³úÁ¹Áß Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³úÁ¹ÁßÀº ³ú·Î °¡´Â Ç÷·ù°¡ ²÷¾îÁö°Å³ª Â÷´ÜµÇ¾î ³ú Á¶Á÷¿¡ »ê¼Ò¿Í ¿µ¾çºÐÀÌ ºÎÁ·ÇØÁö¸é¼­ ¹ß»ýÇÕ´Ï´Ù. ³úÁ¹Áß È¯ÀÚÀÇ Áõ°¡´Â Ç÷°üÀ» ¼Õ»ó½ÃÄÑ ³úÁ¹Áß À§ÇèÀÇ ¿øÀÎÀÌ µÇ´Â °íÇ÷¾ÐÀÇ Áõ°¡¿¡ ±âÀÎÇÏ´Â ¹Ù°¡ Å®´Ï´Ù. ³ú°æ»ö Ä¡·á´Â ³úÇ÷·ù¸¦ ȸº¹½Ã۰í Àå±âÀûÀÎ ¼Õ»ó°ú Àå¾Ö¸¦ ÃÖ¼ÒÈ­ÇÔÀ¸·Î½á ³úÁ¹Áß Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á´Â Àû½Ã¿¡ ÀÇ·áÀû °³ÀÔÀ» ÅëÇØ ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í º¸´Ù È¿°úÀûÀÌ°í °ü¸®Çϱ⠽¬¿î ȸº¹À» °¡Á®¿É´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 9¿ù È£ÁÖ¿¡ º»ºÎ¸¦ µÐ ºñ¿µ¸® ´ÜüÀÎ ³úÁ¹Áß Àç´ÜÀº 2023³â È£ÁÖ¿¡¼­ 4,5,785¸íÀÇ ³úÁ¹Áß È¯ÀÚ°¡ ¹ß»ýÇÏ¿© 2050³â¿¡´Â 7¸¸ 2,000¸í±îÁö Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌó·³ ³úÁ¹Áß À¯º´·üÀÇ Áõ°¡´Â ³úÁ¹Áß Ä¡·á ½ÃÀåÀÇ È®´ë¸¦ ÃËÁøÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

³úÁ¹Áß Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº ±Þ¼º ÇãÇ÷¼º ³úÁ¹Áß È¯ÀÚÀÇ Ä¡·á ½Ã°£À» ´ÜÃàÇϱâ À§ÇØ ÀÌÁß ÈíÀÔ ±â¼ú°ú °°Àº ÷´Ü ±â¼ú °³¹ßÀ» ¿ì¼±½ÃÇϰí ÀÖ½À´Ï´Ù. ÀÌÁß ÈíÀÔ ±â¼úÀº ³úÁ¹Áß ÁßÀç½Ã Ç÷ÀüÁ¦°Å È¿À²À» Çâ»ó½Ã۱â À§ÇØ µÎ °³ÀÇ Ä«Å×Å͸¦ µ¿½Ã¿¡ »ç¿ëÇÏ´Â ±â¼úÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2025³â 5¿ù ¹Ì±¹ÀÇ ÀÇ·á ±â¼ú ±â¾÷ Imperative Care´Â ÃÖ÷´Ü ³úÁ¹Áß Ä¡·á ±â±âÀÎ Zoom DuoPort¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ÇϳªÀÇ Áø°ø ¼Ò½º·Î µÎ °³ÀÇ Ä«Å×Å͸¦ µ¿½Ã¿¡ ÀÛµ¿½ÃÄÑ ÀÌÁß ÈíÀÔÀ» Áö¿øÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ÀÇ»çÀÇ Á¦¾î¸¦ °­È­ÇÏ°í ½Ç½Ã°£ ½Ã¼ú Çǵå¹éÀ» Á¦°øÇÏ¿© ±Þ¼º ÇãÇ÷¼º ³úÁ¹Áß Ä¡·á¿¡¼­ ±â°èÀû Ç÷ÀüÁ¦°Å¼úÀÇ È¿°ú¸¦ ³ôÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Cerebral infarction treatment involves medical interventions designed to restore blood flow to the brain and limit the damage caused by a stroke resulting from blocked blood vessels (ischemic stroke). The primary goal of this treatment is to prevent additional brain injury, reduce neurological impairments, and enhance patient recovery.

The core types of treatment for cerebral infarction include medications, surgical procedures, and rehabilitation therapies. Medications used in this context aim to dissolve blood clots, regulate blood pressure, and prevent future strokes. Diagnostic methods employed in treatment consist of computed tomography (CT) scans, magnetic resonance imaging (MRI), angiography, and Doppler ultrasound. The treatment is applied to conditions such as ischemic stroke, transient ischemic attack, large artery stroke, and small vessel stroke, with end-users including hospitals, dedicated stroke centers, ambulatory surgical centers, and home care services.

The cerebral infarction treatment market research report is one of a series of new reports from The Business Research Company that provides cerebral infarction treatment market statistics, including cerebral infarction treatment industry global market size, regional shares, competitors with a cerebral infarction treatment market share, detailed cerebral infarction treatment market segments, market trends and opportunities, and any further data you may need to thrive in the cerebral infarction treatment industry. This cerebral infarction treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cerebral infarction treatment market size has grown strongly in recent years. It will grow from $11.05 billion in 2024 to $11.84 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to higher healthcare expenditure, an increase in hospital admissions, a rise in minimally invasive stroke procedures, growing demand for mechanical thrombectomy devices, and an expansion in clinical trials.

The cerebral infarction treatment market size is expected to see strong growth in the next few years. It will grow to $15.54 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The projected growth in the forecast period can be attributed to the expanding geriatric population, a rising prevalence of stroke, an increase in cerebrovascular and cardiovascular diseases, and a growing incidence of cerebral infarction. Key trends expected during this period include the integration of telemedicine, the use of wearable health monitoring devices, advancements in neuroimaging techniques, the adoption of robotic-assisted surgery, nanotechnology-based drug delivery systems, and the development of virtual rehabilitation platforms.

The rising prevalence of stroke is anticipated to drive the growth of the cerebral infarction treatment market in the coming years. A stroke occurs when blood flow to the brain is disrupted or blocked, leading to a deficiency of oxygen and nutrients in brain tissue. This increase in stroke cases is largely attributed to the growing incidence of hypertension, which damages blood vessels and contributes to stroke risk. Cerebral infarction treatments play a crucial role in stroke care by restoring cerebral blood flow, minimizing long-term damage and disability. These treatments enhance patient outcomes through timely medical intervention, resulting in more effective and manageable recovery. For example, in September 2024, the Stroke Foundation, an Australia-based not-for-profit organization, reported that Australia experienced 45,785 stroke cases in 2023, with projections indicating a significant increase to 72,000 cases by 2050. Thus, the growing prevalence of stroke is a key factor fueling the expansion of the cerebral infarction treatment market.

Leading companies in the cerebral infarction treatment market are prioritizing the development of advanced technologies, such as dual aspiration technology, to reduce treatment time for patients with acute ischemic stroke. Dual aspiration technology involves the simultaneous use of two catheters to improve the efficiency of clot removal during stroke interventions. For example, in May 2025, Imperative Care, a U.S.-based medical technology company, introduced Zoom DuoPort, a cutting-edge stroke treatment device. This system supports dual aspiration by allowing two catheters to function concurrently with a single vacuum source. It enhances physician control, offers real-time procedural feedback, and increases the effectiveness of mechanical thrombectomy in treating acute ischemic stroke.

In March 2025, Medtronic plc, an Ireland-based medical device company, formed a partnership with Methinks AI to incorporate AI-powered stroke detection software into its neurovascular care solutions. The collaboration is intended to improve early stroke diagnosis, optimize triage processes, and enhance treatment outcomes, particularly in underserved areas. Methinks AI, a digital health company based in Spain, specializes in developing artificial intelligence solutions for the diagnosis and management of stroke.

Major players in the cerebral infarction treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers, Becton, Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Daiichi Sankyo Company Limited, Penumbra Inc., Terumo Corporation, phenox GmbH, Boehringer Ingelheim International GmbH, Imperative Care Inc., Acandis GmbH & Co. KG, Reflow Medical Inc., Lumosa Therapeutics Inc., Insera Therapeutics Inc., Q'Apel Medical Inc.

North America was the largest region in the cerebral infarction treatment market in 2024. The regions covered in cerebral infarction treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cerebral infarction treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cerebral infarction treatment market consists of revenues earned by entities by providing services such as thrombolytic therapy administration, surgical interventions, rehabilitation programs, diagnostic imaging, and post-treatment patient care and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The cerebral infarction treatment market also includes sales of anticoagulants, antiplatelet agents, thrombolytics, neuroprotective drugs, as well as medical devices such as stents, catheters, and diagnostic imaging equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cerebral Infarction Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cerebral infarction treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cerebral infarction treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cerebral infarction treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Cerebral Infarction Treatment Market Characteristics

3. Cerebral Infarction Treatment Market Trends And Strategies

4. Cerebral Infarction Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cerebral Infarction Treatment Growth Analysis And Strategic Analysis Framework

6. Cerebral Infarction Treatment Market Segmentation

7. Cerebral Infarction Treatment Market Regional And Country Analysis

8. Asia-Pacific Cerebral Infarction Treatment Market

9. China Cerebral Infarction Treatment Market

10. India Cerebral Infarction Treatment Market

11. Japan Cerebral Infarction Treatment Market

12. Australia Cerebral Infarction Treatment Market

13. Indonesia Cerebral Infarction Treatment Market

14. South Korea Cerebral Infarction Treatment Market

15. Western Europe Cerebral Infarction Treatment Market

16. UK Cerebral Infarction Treatment Market

17. Germany Cerebral Infarction Treatment Market

18. France Cerebral Infarction Treatment Market

19. Italy Cerebral Infarction Treatment Market

20. Spain Cerebral Infarction Treatment Market

21. Eastern Europe Cerebral Infarction Treatment Market

22. Russia Cerebral Infarction Treatment Market

23. North America Cerebral Infarction Treatment Market

24. USA Cerebral Infarction Treatment Market

25. Canada Cerebral Infarction Treatment Market

26. South America Cerebral Infarction Treatment Market

27. Brazil Cerebral Infarction Treatment Market

28. Middle East Cerebral Infarction Treatment Market

29. Africa Cerebral Infarction Treatment Market

30. Cerebral Infarction Treatment Market Competitive Landscape And Company Profiles

31. Cerebral Infarction Treatment Market Other Major And Innovative Companies

32. Global Cerebral Infarction Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cerebral Infarction Treatment Market

34. Recent Developments In The Cerebral Infarction Treatment Market

35. Cerebral Infarction Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â